Takeo Yoshihara

7PUBLICATIONS
49CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples cultural determinants of healthEpidemiological methodsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 22, 2026
Serum leucine-rich α-2-glycoprotein and monocyte chemoattractant protein-1 as novel biomarkers for predicting vedolizumab response in patients with ulcerative colitis.

|Apr 10, 2026
Selective Drug-Free Active Surveillance in Ulcerative Colitis: Biomarker-Guided, Patient-Centered Approach.

Tsutomu Nishida, Naoto Osugi, Takahiro Amano

|Oct 20, 2025
Outcomes of additional chemotherapy for esophageal squamous cell carcinoma following non-curative endoscopic submucosal dissection.

Yujiro Adachi, Yoshito Hayashi, Shinji Yoneda

|Jul 11, 2025
Optimizing 5-Aminosalicylic Acid Maintenance Treatment in Ulcerative Colitis from the Patient and Physician Perspective: A Cross-sectional Multicenter Study.

Takahiro Amano, Takeo Yoshihara, Tsutomu Nishida

|Apr 23, 2024
Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing.

Tomohiro Fukuda, Hajime Yamazaki, Yusuke Miyatani

|May 24, 2022
Lysophosphatidylserines derived from microbiota in Crohn's disease elicit pathological Th1 response.

Yuriko Otake-Kasamoto, Hisako Kayama, Toshihiro Kishikawa

Pageof 2

Frequent Collaborators

5 joint publications

Tetsuo Takehara

4 joint publications

Shinichiro Shinzaki

4 joint publications

Yoshito Hayashi

3 joint publications

Takahiro Amano